| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8447091 | European Journal of Cancer | 2011 | 10 Pages |
Abstract
After treatment with potential cardiovascular toxic therapies, the risk of systolic and diastolic dysfunction in CCS is considerable. Since these abnormalities, in particular diastolic dysfunction, are age related, the observed effects might be considered a sign of precocious cardiac ageing.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Cornelia A.J. Brouwer, Aleida Postma, Judith M. Vonk, Nynke Zwart, Maarten P. van den Berg, Margreet Th.E. Bink-Boelkens, Wil V. Dolsma, Andries J. Smit, Elisabeth G.E. de Vries, W.J.E. Tissing, Jourik A. Gietema,